Zydus Lifesciences’ Gujarat Plant Receives Warning Letter
The pharma major, Zydus Lifesciences Ltd on 16 September announced that the US Food and Drug Administration (USFDA) has issued a warning letter for its...
Tag : US Food and Drug Administration (USFDA)
Aurobindo Pharma Arm Gets USFDA Approval
Aurobindo Pharma Ltd on Wednesday 11 September announced that its new injectable facility in Andhra Pradesh has secured its first product approval from the US...
Granules India Shares Crash 4% as USFDA Issues Six Observations
Shares of Granules India Ltd crashed 4% on 9 September after the company announced receiving six observations from the US Food and Drug Administration (USFDA). ...
Suven Pharma Shares Hit-52 Week High as USFDA Concludes Investigation of Unit
Shares of Suven Pharmaceuticals Ltd were trading 2% higher and hit a 52-week high of Rs 1,225 on 9 September, following positive developments regarding its...
Strides Pharma Rises Nearly 4% on USFDA Approval for Respiratory Drug from Singapore Arm
Shares of Strides Pharma Science Ltd. surged nearly by 4% to a day’s high of Rs 1,395 on 6th September, after the company’s subsidiary received...
Torrent Pharma Shares Soar 4% as USFDA Issues EIR for Indrad
Shares of Torrent Pharmaceuticals Ltd surged 4% on Friday 30 August, reaching a fresh high of Rs 3,574 on the NSE. This was following the...
Zydus Lifesciences Shares Surge 4% on USFDA Final Approval
Shares of Zydus Lifesciences increased 3.8% to Rs 1156 on Wednesday, 28 August, after the company announced receiving final approval from the US Food and...
Wanbury Shares Surge 5% on Receiving Form 483 With Zero Observation
Shares of Wanbury Ltd surged 5% on 23 August after the company announced receiving an Establishment Inspection Report (EIR) with zero form 483 observations from...
Aurobindo Pharma Shares Drop 6% after Eugia unit-III receives USFDA warning letter
Shares of Aurobindo Pharma Ltd. dropped 6% after touching a day’s high of Rs 1,527 on 16th August, following the company’s disclosure that its Eugia...
Granules India Shares Rise 2% After USFDA Approval for Antidepressant Drug
Shares of Granules India Ltd. rose by nearly 2% to touch a day’s high of Rs 666.30 on 9th August after the USFDA approved its...